Thomas Wild | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Thomas Wild | Medicine and Dentistry | Best Researcher Award

Senoir Consultant at Praxis Dr. Thomas Wild, Germany

Dr. Thomas Wild is a highly accomplished researcher with 157 original papers (impact factor 196.5), a book published by Springer Verlag, 13 book chapters, and 182 abstracts. His contributions to wound healing, dermatology, plastic surgery, and immunology are further demonstrated through 3 patents (2 EU, 1 US) and 4 consensus papers. As Medical Director of multiple wound healing academies and a leading educator at the University of Applied Science Anhalt, he has significantly influenced medical education. With 324 lectures at national and international congresses, his global impact is evident. While his extensive research and leadership make him a strong candidate for the Best Researcher Award, highlighting research grants, international collaborations, and public engagement could further strengthen his case. Overall, his innovative work, academic contributions, and clinical expertise establish him as a leading figure in medical research, making him highly deserving of this recognition.

Professional ProfileĀ 

Education

Dr. Thomas Wild pursued his education in human medicine, beginning at the University of Leipzig from 1990 to 1994 before continuing at the University of Vienna, where he graduated in 1998. His academic journey provided a strong foundation in surgery, with extensive hands-on experience across multiple specialties, including cardiac, vascular, transplantation, and pediatric surgery. Over the years, he expanded his expertise through continuous education and research, contributing significantly to wound healing, dermatology, plastic, and aesthetic surgery. Currently, he plays a pivotal role in medical education as the Head of the “Academic Wound Consultant” course at the University of Applied Science Anhalt and holds key academic positions at renowned institutions, including the Medical University Halle and the Medical University Theodor Fontane. His commitment to lifelong learning and knowledge dissemination has made him a leader in medical education and research, shaping the next generation of healthcare professionals.

Professional Experience

Dr. Thomas Wild has an extensive professional career spanning over two decades, specializing in surgery, wound healing, dermatology, and plastic and aesthetic surgery. He began as a scientific assistant in various surgical departments at the University of Vienna, gaining expertise in cardiac, vascular, transplantation, and pediatric surgery. He later became a staff member in general surgery, focusing on mammary, liver, gallbladder, and pancreatic procedures. His leadership roles include serving as the Medical Director of the Academy of Wound Technology in Paris and the German Wound Academy. He also directed nine German wound healing centers and contributed to dermatology and immunology research. Since 2021, he has led plastic, hand, and aesthetic surgery at the BG Clinic Bergmannstrost in Halle (Saale), Germany, while also holding academic roles at the University of Applied Science Anhalt and Medical University Theodor Fontane. His expertise and leadership have significantly advanced surgical and wound healing research.

Research Interest

Dr. Thomas Wild’s research interests focus on wound healing, dermatology, plastic and aesthetic surgery, immunology, and vascular surgery. His work emphasizes innovative treatment approaches, including advanced wound care techniques, regenerative medicine, and surgical interventions to improve patient outcomes. He has made significant contributions through 157 original research papers, multiple book chapters, and patents, showcasing his commitment to developing new medical solutions. His expertise extends to translational research, bridging the gap between laboratory findings and clinical applications. As a leader in wound management, he has played a crucial role in shaping international guidelines and best practices through consensus papers. Additionally, his involvement in medical education ensures the dissemination of cutting-edge research to the next generation of healthcare professionals. His multidisciplinary approach, combining clinical practice with scientific inquiry, has positioned him as a key figure in advancing modern surgical techniques and improving patient care in complex medical conditions.

Award and Honor

Dr. Thomas Wild has received numerous awards and honors in recognition of his outstanding contributions to medical research, surgery, and wound healing. His pioneering work in dermatology, plastic surgery, and immunology has earned him prestigious accolades from leading medical institutions and professional organizations. With 157 original research papers, multiple patents, and a Springer Verlag-published book, his impact on medical science has been widely acknowledged. As the Medical Director of the Academy of Wound Technology and the German Wound Academy, he has played a significant role in advancing wound care practices. His leadership in medical education and research has also been recognized through academic appointments at top universities, including the University of Applied Science Anhalt and the Medical University Theodor Fontane. Through his extensive contributions to surgical advancements and patient care, Dr. Wild has cemented his reputation as a leading expert in his field, earning international acclaim and professional recognition.

Research Skill

Dr. Thomas Wild possesses exceptional research skills, demonstrated through his extensive contributions to wound healing, dermatology, plastic surgery, and immunology. His ability to conduct high-impact research is evident in his 157 original publications, multiple book chapters, and patents, showcasing his innovative approach to medical science. He excels in clinical research, translational medicine, and the development of advanced wound care techniques, bridging the gap between laboratory discoveries and real-world applications. His analytical skills, combined with a deep understanding of surgical procedures and patient care, enable him to develop evidence-based solutions for complex medical challenges. Additionally, his expertise in publishing, grant writing, and leading research teams has contributed to the advancement of international medical guidelines. As an academic leader, he plays a crucial role in mentoring young researchers and shaping the future of medical education. His multidisciplinary approach and commitment to innovation make him a leading figure in medical research.

Conclusion

Dr. Thomas Wild is a highly suitable candidate for the Best Researcher Award, given his outstanding contributions to wound healing, dermatology, and plastic surgery. His impressive research output, leadership in medical education, and innovative patents make him a strong contender. Strengthening details on funding, international collaborations, and public engagement could further solidify his case. Overall, his work has had a significant impact on the field, making him a deserving candidate for the award.

Publications Top Noted

  • Hallas, S., Nelson, E.A., O’Meara, S.M., Tawfick, W.A., Wild, T. (2024). Development of a core outcome set for use in research evaluations of interventions for venous leg ulceration: International eDelphi consensus. Journal of Tissue Viability

  • Wild, T., Aljowder, A.A., AlJawder, A.A.A., Marotz, J., Siemers, F. From Wound to Scar: Scarring Explainedā€”Pathophysiology of Wound Healing. [Book Chapter] ā€“ 1 Citation

  • Traber, J., Wild, T., Marotz, J., Berli, M.C., Franco-ObregĆ³n, A. (2023). Concurrent Optical- and Magnetic-Stimulation-Induced Changes on Wound Healing Parameters, Analyzed by Hyperspectral Imaging: An Exploratory Case Series. Bioengineering ā€“ 6 Citations

  • Snyder, R.J., Driver, V.R., Cole, W.E., Kaufman, J.P., Wild, T. (2023). Topical Autologous Blood Clot Therapy: Consensus Panel Recommendations to Guide Use in the Treatment of Complex Wound Types. Wounds ā€“ 1 Citation

  • Snyder, R.J., Driver, V.R., Cole, W.E., Kaufman, J.P., Wild, T. (2022). Topical Autologous Blood Clot Therapy: An Introduction and Development of Consensus Panel to Guide Use in the Treatment of Complex Wound Types. Wounds ā€“ 3 Citations

  • Hallas, S., Nelson, E.A., O’Meara, S.M., Wild, T., Gethin, G. (2021). Development of a core outcome set for venous leg ulceration (CoreVen) research evaluations (protocol). Journal of Tissue Viability ā€“ 3 Citations

  • Marotz, J., Schulz, T., Seider, S., Wild, T., Siemers, F. (2021). 3D-perfusion analysis of burn wounds using hyperspectral imaging. Burns ā€“ 13 Citations

  • Zouboulis, C.C., Wild, T., Zouboulis, V.A., Har-Shai, Y. (2021). Intralesional cryosurgery of keloids: required treatment hold time. British Journal of Dermatology ā€“ 7 Citations

BetĆ¼l Kilincli | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Mrs. BetĆ¼l Kilincli | Medicine and Dentistry | Best Researcher Award

PhD candidate at Adana Alparslan Turkes Science and Technology Universty, Turkey

Betul Kilincli is a dedicated researcher specializing in food engineering, biotechnology, and nanotechnology. Her expertise spans the production and characterization of functional food components, biosensors, and microfluidic applications. She has received multiple prestigious scholarships, including the BIDEB PhD Scholarship and the YOK 100/2000 PhD Scholarship. With a strong background in interdisciplinary research, she actively contributes to projects involving nanotechnology, food safety, and biomedical applications. Her work includes published research in high-impact journals and numerous conference presentations.

Professional ProfileĀ 

Education

Betul Kilincli is pursuing a Ph.D. in Food Engineering at Adana Alparslan Turkes Science and Technology University, focusing on proniosomal olive leaf extract powder. She earned her Masterā€™s degree in Food Engineering from Cukurova University, where she researched Turkmen fringe cheese. Additionally, she completed pedagogical training at Mersin University and participated in the Farabi Exchange Program at Erciyes University. She holds a Bachelorā€™s degree in Food Engineering from Munzur University.

Professional Experience

Betul Kilincli has extensive experience in both industry and academia. She currently works as a researcher at the National Nanotechnology Research Center at Bilkent University, contributing to interdisciplinary projects. Previously, she was a food engineer at Oguz Food Industry and Canipek Food Production. She has been actively involved in grant applications, laboratory management, and experimental design. Her experience also includes mentoring students and conducting research on biosensors, food safety, and microfluidic applications.

Research Interests

Betul Kilincli’s research focuses on food engineering, biotechnology, and nanotechnology, with a particular emphasis on functional food components, biosensors, and microfluidic applications. She is deeply engaged in developing innovative approaches for food preservation, bioactive compound delivery, and food safety monitoring. Her work integrates advanced nanomaterials with food science to enhance the stability, bioavailability, and efficacy of bioactive ingredients. She is also interested in the applications of biosensors for detecting contaminants in food products and biomedical diagnostics.

Awards and Honors

Betul Kilincli has been recognized with several prestigious scholarships and awards for her contributions to food engineering and biotechnology. She received the BIDEB PhD Scholarship from TƜBİTAK, the YOK 100/2000 PhD Scholarship, and the International Research Scholarship from TƜBİTAK for her studies abroad. Additionally, she has been honored for her research presentations at international conferences and has contributed to high-impact scientific journals, showcasing her expertise and innovation.

Research Skills

Betul Kilincli possesses strong research skills in nanotechnology, biosensors, and microfluidics, along with expertise in analytical techniques such as FTIR, SEM, HPLC, and UV-Vis spectroscopy. She is proficient in formulating and characterizing functional food components, including nanoencapsulation and proniosome-based delivery systems. Her skills also extend to experimental design, data analysis, and grant writing. Additionally, she has experience working in multidisciplinary research teams, conducting laboratory experiments, and mentoring students in advanced food engineering and biotechnology projects.

Conclusion

Betul Kilincli is a highly qualified and accomplished researcher in the fields of food engineering, nanotechnology, and biotechnology. Her contributions in biosensors, microfluidics, and food safety research make her a strong candidate for the Best Researcher Award. With additional high-impact publications, global collaborations, and commercialization efforts, she could further strengthen her candidacy and influence in the scientific community.

Publications Top Noted

  • The risk estimation and assessment of heavy metal exposure by biomonitoring in the breast milk of mothers in the Cukurova Region, Turkey

    • Authors: E. Nazlıcan, E. Arıca, Ä°. E. Gƶren, B. KılınƧlı, B. Mete, N. Dağlıoğlu
    • Year: 2022
    • Citations: 9

  • Biosensor for ATP detection via aptamer-modified PDA@ POSS nanoparticles synthesized in a microfluidic reactor

    • Authors: G. Kibar, O. B. Şahinoğlu, B. KılınƧlı, E. Y. Erdem, B. Ƈetin, V. C. Ɩzalp
    • Year: 2024
    • Citations: 7

  • Local Cheese Varieties in the Mediterranean Region

    • Authors: N. GĆ¼zeler, B. KılınƧlı
    • Year: 2018
    • Citations: 2

  • Microfluidic vs. batch synthesis of fluorescent poly (GMA-co-EGDMA) micro/nanoparticles for biomedical applications

    • Authors: B. KılınƧlı, A. D. Ƈınar, B. Ƈetin, G. Kibar
    • Year: 2024
    • Citations: Not available

  • Investigation of macroelement and mineral values in breast milk in the first six months postpartum

    • Authors: E. Nazlıcan, B. KılınƧlı, B. E. Yoldaşcan, N. GĆ¼zeler, A. R. Abdul-Aziz
    • Year: 2021
    • Citations: Not available

  • SĆ¼per Meyvelerin Ä°nsan Sağlığı Ɯzerine Etkileri

    • Author: B. KılınƧlı
    • Year: 2020
    • Citations: Not available

  • Kars Ardahan illerinde Ć¼retilerek satışa sunulan TĆ¼rkmen saƧak peynirlerinin kalite ƶzellikleri

    • Author: B. KılınƧlı
    • Year: 2019
    • Citations: Not available

  • Baby Nutrition and Industrial Baby Foods

    • Authors: F. Koboyeva, N. GĆ¼zeler, B. KılınƧlı, E. Kadir
    • Year: 2018
    • Citations: Not available

MarĆ­lia Dourado | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Assoc. Prof. Dr. MarĆ­lia Dourado | Medicine and Dentistry | Best Researcher Award

Professora Doutora at Faculdade de Medicina- Universidade de Coimbra, Portugal

MarĆ­lia de AssunĆ§Ć£o Rodrigues Ferreira Dourado is an esteemed researcher and professor at the Faculty of Medicine, University of Coimbra. With extensive contributions in palliative care, pain medicine, and oncobiology, she has played a key role in advancing research on symptom control, pharmacological prescriptions, and cost-effectiveness in healthcare. She has authored over 30 peer-reviewed journal articles, 15 book chapters, and 162 conference abstracts, highlighting her dedication to academic excellence. Additionally, she has mentored over 70 masterā€™s and PhD students, fostering the next generation of healthcare researchers.

Professional ProfileĀ 

Education

MarĆ­lia Dourado holds a distinguished academic background in medicine and research. She is a Professor with Aggregation at the Faculty of Medicine, University of Coimbra, and possesses Competence in Experimental Pathology from the Portuguese Medical Association. Her commitment to palliative care education and research is evident through the programs she has established, such as the Masterā€™s in Continuing and Palliative Care and the Postgraduate Program in Pain Medicine.

Professional Experience

With a robust career in academia and research, MarĆ­lia Dourado is a Professor at the Faculty of Medicine, University of Coimbra, where she teaches and coordinates multiple programs. She established the Center for Studies and Development of Palliative Care (CEDCP) and leads research on biomarkers for pain, symptom control, and caregiver support. She is also an active member of the International Association for Hospice and Palliative Care (IAHPC), contributing to global advancements in palliative medicine.

Research Interest

MarĆ­lia de AssunĆ§Ć£o Rodrigues Ferreira Douradoā€™s research primarily focuses on palliative care, pain medicine, and oncobiology. She has made significant contributions in symptom control, pharmacological prescriptions for end-of-life care, and the cost-effectiveness of palliative treatments. Her work also includes the development and validation of health measurement instruments, ensuring accurate assessment in clinical settings. Additionally, she explores biomarkers for pain diagnosis and treatment, aiming to improve pain management strategies. Her research extends to training and supporting informal caregivers, emphasizing the importance of holistic care in palliative settings.

Awards and Honors

MarĆ­lia Dourado has been recognized for her contributions to medical research, education, and healthcare innovation. She has received accolades for her work in palliative care development, research excellence, and academic leadership. Her role in creating and coordinating specialized programs has earned her professional recognition both nationally and internationally. As a member of the International Association for Hospice and Palliative Care (IAHPC), she continues to influence the field globally.

Research Skills

MarĆ­lia Dourado possesses a diverse set of research skills spanning clinical research, health assessment methodologies, and pharmacological studies. She specializes in qualitative and quantitative research methods, systematic reviews, and clinical trial design. Her expertise includes biomarker identification for pain, validation of health measurement instruments, and cost-effectiveness analysis in palliative care. Additionally, she is adept at mentoring researchers, designing curriculum-based research programs, and publishing in high-impact journals. Her interdisciplinary approach enables her to bridge clinical practice with innovative healthcare solutions.

Conclusion

MarĆ­lia de AssunĆ§Ć£o Rodrigues Ferreira Dourado is a highly qualified and impactful researcher in palliative care, pain medicine, and oncobiology, making her a strong candidate for the Best Researcher Award. Her leadership in academic programs, research contributions, and mentoring efforts support her candidacy. To further strengthen her position, she could focus on increasing high-impact publications, securing major research grants, and expanding international collaborations.

Publications Top Noted

  • Opioids and Constipation Therapy in the Last Week of Life: Their Impact on Patients, Caregivers, and the Location of Death
    Authors: Ribeiro H, MagalhĆ£es J, Cardoso T, Chaves-Castro I, Lopes-Mota C, Costa E, Rocha P, Lopes L, BouƧa Ƃ, Pereira C, Dourado M et al.
    Year: 2023
    Citation: Ribeiro H et al., Medicine, 2023, DOI: 10.1097/md.0000000000032718

  • Platelet Membrane Proteins as Pain Biomarkers in Patients with Severe Dementia
    Authors: Ribeiro H, Alves R, Jorge J, GonƧalves AC, Sarmento-Ribeiro AB, Teixeira-Verƭssimo M, Dourado M, Andrade JP
    Year: 2023
    Citation: Ribeiro H et al., Biomedicines, 2023, DOI: 10.3390/biomedicines11020380

  • “Dignity as a Small Candle Flame That Doesn’t Go Out!”: An Interpretative Phenomenological Study with Patients Living with Advanced Chronic Obstructive Pulmonary Disease
    Authors: Laranjeira C, Dourado M
    Year: 2022
    Citation: Laranjeira C & Dourado M, International Journal of Environmental Research and Public Health, 2022, DOI: 10.3390/ijerph192417029

  • Novel Non-Viral Vectors Based on PluronicĀ® F68PEI with Application in Oncology Field
    Authors: Silva I, Domingues C, Jarak I, Carvalho RA, Cordeiro RA, Dourado M, Veiga F, Faneca H, Figueiras A
    Year: 2022
    Citation: Silva I et al., Polymers, 2022, DOI: 10.3390/polym14235315

  • Where Is Nano Today and Where Is It Headed? A Review of Nanomedicine and the Dilemma of Nanotoxicology
    Authors: Domingues C, Santos A, Alvarez-Lorenzo C, Concheiro A, Jarak I, Veiga F, Barbosa I, Dourado M, Figueiras A
    Year: 2022
    Citation: Domingues C et al., ACS Nano, 2022, DOI: 10.1021/acsnano.2c00128

  • Apoptosis and (in) Pain-Potential Clinical Implications
    Authors: Ribeiro H, Sarmento-Ribeiro AB, Andrade JP, Dourado M
    Year: 2022
    Citation: Ribeiro H et al., Biomedicines, 2022, DOI: 10.3390/biomedicines10061255

  • Prescription Trends at the End of Life in a Palliative Care Unit: Observational Study
    Authors: Peralta T, Castel-Branco MM, Reis-Pina P, Figueiredo IV, Dourado M
    Year: 2022
    Citation: Peralta T et al., BMC Palliative Care, 2022, DOI: 10.1186/s12904-022-00954-z

  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Pain and Aging: Adjusting Prescription to Patient Features
    Authors: Ribeiro H, Rodrigues I, NapoleĆ£o L, Lira L, Marques D, VerĆ­ssimo M, Andrade JP, Dourado M
    Year: 2022
    Citation: Ribeiro H et al., Biomedicine & Pharmacotherapy, 2022, DOI: 10.1016/j.biopha.2022.112958

  • The Portuguese Performance Assessment of Self-Care Skills Measure: Validity and Reliability
    Authors: Ferreira PL, SimƵes AL, Dourado M, Holm MB, Rogers JC
    Year: 2021
    Citation: Ferreira PL et al., OTJR: Occupation, Participation and Health, 2021, DOI: 10.1177/15394492211021309

  • Validity and Reliability of the Portuguese-Performance Assessment of Self-Care Skills (P-PASS) for Individuals with Disabilities
    Authors: Ferreira PL, SimƵes AL, Dourado M, Holm MB, Rogers JC
    Year: 2020
    Citation: Ferreira PL et al., Preprint, 2020, DOI: 10.21203/rs.3.rs-60570/v3

  • Knowledge of Palliative Care Among Medical Students of the University of Coimbra
    Authors: Oliveira S, Santiago LM, Dourado M
    Year: 2020
    Citation: Oliveira S et al., Acta Medica Portuguesa, 2020, DOI: 10.20344/amp.12590

  • Validity and Reliability of the Portuguese-Performance Assessment of Self-Care Skills (P-PASS) for Portuguese Individuals with Disabilities
    Authors: Ferreira PL, SimƵes AL, Dourado M, Holm MB, Rogers JC
    Year: 2020
    Citation: Ferreira PL et al., Preprint, 2020, DOI: 10.21203/rs.3.rs-53489/v1

Liying Zhang | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Liying Zhang | Medicine and Dentistry | Best Researcher Award

Professor at University of California, Los Angeles, United States

Dr. Liying Zhang, MD, PhD, FACMG, is a distinguished researcher and professor specializing in molecular diagnostics and precision oncology. She serves as the Director of the Advanced Molecular Diagnostics Service at UCLA David Geffen School of Medicine and the Director of Cancer Molecular Diagnostics at UCLA Jonsson Comprehensive Cancer Center. With extensive experience in molecular genetics, her research focuses on cancer diagnostics, biomarker discovery, and precision medicine. She has contributed to numerous high-impact studies, secured significant research funding, and played an active role in national and international expert committees. Her expertise spans clinical molecular genetics, genomics, bioinformatics, and laboratory medicine, making her a leading figure in the field of cancer molecular diagnostics.

Professional ProfileĀ 

Education

Dr. Zhang earned her Ph.D. in Biochemistry and Molecular Biology from The Johns Hopkins University in 2003, alongside a Masterā€™s degree in Computer Science with a focus on Bioinformatics in 2002. She obtained her MD from Peking University, Beijing, China, in 1994. She holds multiple clinical licensures and board certifications, including Clinical Molecular Genetics and Genomics from the American Board of Medical Genetics and Genomics. Her strong educational foundation in medicine, biochemistry, molecular biology, and computational science has equipped her with the interdisciplinary expertise required for advancing molecular diagnostics and precision medicine.

Professional Experience

Dr. Zhang has held several prestigious roles in molecular pathology and diagnostics. Since 2020, she has been a Professor and Director at UCLA, leading advanced molecular diagnostics initiatives. Previously, she served as a Director and Molecular Geneticist at Memorial Sloan Kettering Cancer Center from 2005 to 2019, overseeing diagnostic molecular genetics laboratories and contributing to groundbreaking cancer research. Her earlier roles include research positions at the National Research Institute for Family Planning in China. Additionally, she has been actively involved in professional committees, journal reviews, and mentorship programs, furthering advancements in molecular diagnostics and genetic research.

Research Interest

Dr. Liying Zhang’s research focuses on molecular diagnostics, cancer genomics, and precision oncology. She is dedicated to identifying genetic biomarkers that enhance cancer detection, prognosis, and treatment strategies. Her work involves integrating next-generation sequencing (NGS) technologies, bioinformatics, and molecular pathology to improve the accuracy and efficiency of cancer diagnostics. She is particularly interested in the molecular mechanisms underlying tumor development, drug resistance, and targeted therapies. Through collaborations with oncologists, geneticists, and data scientists, she aims to translate genetic findings into clinically actionable insights that improve patient outcomes. Her research also extends to liquid biopsy, epigenetics, and the development of novel molecular assays for early cancer detection.

Awards and Honors

Dr. Zhang has received numerous prestigious awards recognizing her contributions to molecular genetics and cancer diagnostics. She has been honored as a Fellow of the American College of Medical Genetics and Genomics (FACMG), acknowledging her leadership and expertise in clinical molecular genetics. She has also received research excellence awards from institutions such as Memorial Sloan Kettering Cancer Center and UCLA for her groundbreaking work in cancer molecular diagnostics. Additionally, she has been an invited speaker at leading international conferences, including the American Society of Human Genetics (ASHG) and the Association for Molecular Pathology (AMP). Her contributions to scientific research and clinical practice have earned her recognition as a thought leader in precision medicine and molecular oncology.

Research Skills

Dr. Zhang possesses a diverse range of research skills in molecular diagnostics and genomics. She is proficient in next-generation sequencing (NGS) technologies, whole-genome and transcriptome analysis, and single-cell sequencing. She has extensive experience in bioinformatics, data mining, and computational modeling for genetic variant interpretation. Her expertise includes designing and validating molecular assays for clinical diagnostics, including PCR-based and hybrid capture-based sequencing methods. She is also skilled in laboratory management, regulatory compliance, and quality control in clinical molecular genetics laboratories. Additionally, her strong background in translational research allows her to bridge the gap between basic scientific discoveries and clinical applications, ensuring that her findings have a direct impact on patient care and personalized treatment strategies.

Conclusion

Dr. Liying Zhang is highly suitable for the Best Researcher Award due to her exceptional contributions to molecular diagnostics, cancer genomics, and precision medicine. Her extensive experience in research leadership, grant acquisition, and clinical applications makes her an outstanding candidate. Strengthening her independent research leadership and international collaborations would further solidify her candidacy for this prestigious award.

Publications Top Noted

  • Title: Inherited DNA-repair gene mutations in men with metastatic prostate cancer
    Authors: CC Pritchard, J Mateo, MF Walsh, N De Sarkar, W Abida, H Beltran, …
    Year: 2016
    Citation: 1765

  • Title: Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer
    Authors: L Klotz, L Zhang, A Lam, R Nam, A Mamedov, A Loblaw
    Year: 2010
    Citation: 1402

  • Title: Long-term follow-up of a large active surveillance cohort of patients with prostate cancer
    Authors: L Klotz, D Vesprini, P Sethukavalan, V Jethava, L Zhang, S Jain, …
    Year: 2015
    Citation: 1399

  • Title: CT angiography clot burden score and collateral score: correlation with clinical and radiologic outcomes in acute middle cerebral artery infarct
    Authors: IYL Tan, AM Demchuk, J Hopyan, L Zhang, D Gladstone, K Wong, …
    Year: 2009
    Citation: 792

  • Title: Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance
    Authors: J Holzbeierlein, P Lal, E LaTulippe, A Smith, J Satagopan, L Zhang, …
    Year: 2004
    Citation: 708

  • Title: Microsatellite instability is associated with the presence of Lynch syndrome pan-cancer
    Authors: A Latham, P Srinivasan, Y Kemel, J Shia, C Bandlamudi, D Mandelker, …
    Year: 2019
    Citation: 591

  • Title: Prospective genomic profiling of prostate cancer across disease states reveals germline and somatic alterations that may affect clinical decision making
    Authors: W Abida, J Armenia, A Gopalan, R Brennan, M Walsh, D Barron, D Danila, …
    Year: 2017
    Citation: 583

  • Title: Celiac disease: summary
    Authors: A Rostom, C DubĆ©, A Cranney, N Saloojee, R Sy, C Garritty, M Sampson, …
    Year: 2004
    Citation: 511

  • Title: Mutation detection in patients with advanced cancer by universal sequencing of cancer-related genes in tumor and normal DNA vs guideline-based germline testing
    Authors: D Mandelker, L Zhang, Y Kemel, ZK Stadler, V Joseph, A Zehir, …
    Year: 2017
    Citation: 508

  • Title: Tumour lineage shapes BRCA-mediated phenotypes
    Authors: P Jonsson, C Bandlamudi, ML Cheng, P Srinivasan, SS Chavan, …
    Year: 2019
    Citation: 384

  • Title: Hereditary diffuse gastric cancer: updated clinical practice guidelines
    Authors: VR Blair, M McLeod, F Carneiro, DG Coit, JL D’Addario, JM van Dieren, …
    Year: 2020
    Citation: 381

  • Title: Update of the international consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases
    Authors: E Chow, P Hoskin, G Mitera, L Zeng, S Lutz, D Roos, C Hahn, …
    Year: 2012
    Citation: 374

  • Title: Reliable pan-cancer microsatellite instability assessment by using targeted next-generation sequencing data
    Authors: S Middha, L Zhang, K Nafa, G Jayakumaran, D Wong, HR Kim, …
    Year: 2017
    Citation: 363

  • Title: Genetic predictors of response to systemic therapy in esophagogastric cancer
    Authors: YY Janjigian, F Sanchez-Vega, P Jonsson, WK Chatila, JF Hechtman, …
    Year: 2018
    Citation: 352

Calogero Velluto | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Calogero Velluto | Medicine and Dentistry | Best Researcher Award

MD at UniversitĆ  cattolica del sacro cuore, roma, Italy

Dr. Calogero Velluto is a distinguished spine surgeon and researcher specializing in orthopedic and oncological sciences. His expertise lies in spinal surgery, minimally invasive techniques, and oncological spine disorders. He has contributed significantly to the field through numerous research publications, international fellowships, and active participation in prestigious medical societies. Dr. Velluto’s academic journey, extensive clinical experience, and commitment to advancing spinal surgery through research make him a notable candidate for the Best Researcher Award.

Professional ProfileĀ 

Education

Dr. Velluto earned his degree in Medicine and Surgery from the UniversitĆ  degli Studi di Messina in 2018, graduating with honors. He obtained his medical license in 2019 and completed a residency in Orthopedic Surgery at UniversitĆ  Cattolica del Sacro Cuore in 2024. Currently, he is pursuing a Ph.D. in Oncological Sciences at the same university. Additionally, he has attended specialized training programs such as the AO Spine Course and Spine Academy.

Professional Experience

Dr. Velluto has held key roles in spine surgery at Fondazione Policlinico Universitario A. Gemelli IRCCS. He completed an international research fellowship at the San Diego Spine Foundation and underwent mentorship at Mayo Clinic. His experience includes pediatric orthopedic surgery at Ospedale Pediatrico Bambino GesĆ¹ and emergency medicine in Messina. As a dedicated researcher, he has published extensively on spinal deformities, fracture treatments, and minimally invasive spine surgery techniques.

Research Interests

Dr. Calogero Velluto’s research focuses on spinal surgery, minimally invasive techniques, and oncological spine disorders. His primary interests include spinal deformities, vertebral fractures, and advanced surgical treatments for spinal tumors. He actively investigates innovative approaches to enhance surgical outcomes, optimize recovery, and improve the quality of life for patients with complex spinal conditions. Additionally, he is involved in clinical studies exploring novel biomaterials and implants for spine stabilization. His research contributions aim to bridge the gap between surgical practice and cutting-edge medical advancements.

Awards and Honors

Dr. Velluto has received multiple accolades for his contributions to orthopedic and spine surgery. He was awarded the Best Paper Presentation at international spine conferences and has been recognized for his outstanding research in spinal oncology. His participation in prestigious fellowships, such as the San Diego Spine Foundation Research Fellowship, highlights his excellence in spine surgery. His work has earned recognition from renowned medical societies and academic institutions.

Research Skills

Dr. Velluto possesses a strong skill set in clinical and experimental research, particularly in orthopedic and spinal surgery. He is proficient in biomechanical testing, data analysis, and statistical modeling for surgical outcomes. His expertise extends to advanced imaging techniques, including MRI and CT-based diagnostic evaluations. He has significant experience in conducting systematic reviews, writing scientific publications, and collaborating on multi-institutional studies. His ability to integrate research with clinical practice allows him to develop innovative, evidence-based treatment approaches in spinal surgery.

Conclusion

Calogero Velluto is a strong candidate for the Best Researcher Award, given his extensive research contributions, international collaborations, and academic excellence in spine surgery. To further strengthen his candidacy, he should focus on increasing his research impact through higher citation metrics, securing independent funding, and diversifying his research portfolio.

Publications Top Noted

  • Title: Incidence and Risk Assessment of Acute Kidney Injury (AKI) in Spine Surgery: A Case Report and Literature Review
    Authors: Calogero Velluto, Giovan Giuseppe Mazzella, Laura Scaramuzzo, Maria Ilaria Borruto, Michele Inverso, Lorenzo Fulli, Matteo Costanzi, Marco Rossi, Luca Proietti
    Year: 2025
    Citation: Journal of Clinical Medicine, DOI: 10.3390/jcm14041210

  • Title: Epidemiology, Diagnosis, Management, and Prognosis of Spinal Metastasis: The State-of-the-Art
    Authors: Andrea Perna, Calogero Velluto, Amarildo Smakaj, Maria Concetta Meluzio, Maria Ilaria Borruto, Raffaele Vitiello, Giulio Maccauro, Andrea Franchini, Franco Lucio Gorgoglione, Luca Proietti
    Year: 2024
    Citation: Book chapter, DOI: 10.1007/16833_2024_304

  • Title: Impact of a Novel Antiseptic Lavage Solution on Acute Periprosthetic Joint Infection in Hip and Knee Arthroplasty
    Authors: Luca Andriollo, Rudy Sangaletti, Calogero Velluto, Loris Perticarini, Francesco Benazzo, Stefano Marco Paolo Rossi
    Year: 2024
    Citation: Journal of Clinical Medicine, DOI: 10.3390/JCM13113092

  • Title: Radiological Evaluation of Fusion Patterns After Lateral Lumbar Interbody Fusion With 3D-Printed Porous Titanium Cages vs. Conventional Titanium Cages
    Authors: Calogero Velluto, Gregory Mundis Jr, Laura Scaramuzzo, Andrea Perna, Giacomo Capece, Andrea Cruciani, Michele Inverso, Maria Ilaria Borruto, Luca Proietti
    Year: 2024
    Citation: Frontiers in Surgery, DOI: 10.3389/FSURG.2024.1446792

  • Title: Rethinking Strategies for Multi-Metastatic Patients: A Comprehensive Retrospective Analysis on Open Posterior Fusion Versus Percutaneous Osteosynthesis in the Treatment of Vertebral Metastases
    Authors: Laura Scaramuzzo, Andrea Perna, Calogero Velluto, Maria Ilaria Borruto, Franco Lucio Gorgoglione, Luca Proietti
    Year: 2024
    Citation: Journal of Clinical Medicine, DOI: 10.3390/JCM13113343

  • Title: The Incidence of Screw Failure in Fenestrated Polyaxial Pedicle Screws vs. Conventional Pedicle Screws in the Treatment of Adolescent Idiopathic Scoliosis (AIS)
    Authors: Calogero Velluto, Michele Inverso, Maria Ilaria Borruto, Andrea Perna, Guido Bocchino, Davide Messina, Luca Proietti
    Year: 2024
    Citation: Journal of Clinical Medicine, DOI: 10.3390/JCM13061760

  • Title: The Use of an Imageless Robotic System in Revision of Unicompartmental Knee Arthroplasty
    Authors: Luca Andriollo, Francesco Benazzo, Virgina Cinelli, Rudy Sangaletti, Calogero Velluto, Stefano Marco Paolo Rossi
    Year: 2024
    Citation: Knee Surgery, Sports Traumatology, Arthroscopy, DOI: 10.1002/ksa.12574

  • Title: Enhancing MRI Report Comprehension in Spinal Trauma: An Analysis of AI-Generated Explanations for Thoracolumbar Fractures (Preprint)
    Authors: David C. Sing, Kishan S. Shah, Michael Pompliano, Paul H. Yi, Calogero Velluto, Ali Bagheri, Robert K. Eastlack, Stephen Stephan, Gregory M. Mundis
    Year: 2024
    Citation: DOI: 10.2196/preprints.69654

  • Title: Clinical and Radiographic Results in Thoracic Hyperkyphosis Surgical Treatment Considering the Optimal Distal Fusion Area
    Authors: Laura Scaramuzzo, Fabrizio Giudici, Calogero Velluto, Giuseppe Barone, Maria Concetta Meluzio, Antonino Zagra, Luca Proietti
    Year: 2024
    Citation: Journal of Clinical Medicine, DOI: 10.3390/jcm13226799

JosƩ Kennedy Amaral | Medicine and Dentistry | Best Scholar Award

Posted on by ScienceFather

Dr. JosƩ Kennedy Amaral | Medicine and Dentistry | Best Scholar Award

Post Graduate Student at FEDERAL UNIVERSITY OF CARIRI, BrazilĀ 

Dr. JosĆ© Kennedy Amaral Pereira is a distinguished medical professional specializing in rheumatology, with a strong academic and research background in health sciences. He earned his medical degree from Faculdade de Medicina EstĆ”cio de Juazeiro do Norte (2013) and pursued multiple specializations, including Rheumatology and Family Health. Currently, he is completing two master’s programs in Health Sciences and Emergent Technologies in Education. Dr. Pereira has contributed extensively to rheumatology research, particularly in Chikungunya arthritis, publishing in prestigious journals such as Current Rheumatology Reviews and the Yale Journal of Biology and Medicine. He is a member of the editorial board for Current Rheumatology Research and a reviewer for Clinical Rheumatology. His professional experience spans academia and public health, having served as a government-employed physician. Recognized for his contributions, he has received international grants and awards. Dr. Pereiraā€™s work significantly impacts the understanding and management of rheumatic diseases globally.

Professional ProfileĀ 

Education

Dr. JosĆ© Kennedy Amaral Pereira has a diverse and extensive educational background in medicine and health sciences. He earned his medical degree from Faculdade de Medicina EstĆ”cio de Juazeiro do Norte in 2013, laying the foundation for his specialization in rheumatology and family health. Further advancing his expertise, he completed postgraduate studies in Rheumatology at the Instituto de Pesquisa e EducaĆ§Ć£o em SaĆŗde de SĆ£o Paulo (IPES) and Family Health at Universidade EstĆ”cio de SĆ”. Demonstrating a commitment to continuous learning, he is currently pursuing two masterā€™s degreesā€”one in Health Sciences at Universidade de Pernambuco and another in Emergent Technologies in Education at Must University. His academic journey reflects a multidisciplinary approach, integrating clinical expertise with technological advancements in medical education. Through his rigorous training and research endeavors, Dr. Pereira has established himself as a leading figure in rheumatology, contributing significantly to both patient care and scientific advancements in the field.

Professional Experience

Dr. JosĆ© Kennedy Amaral Pereira has built a distinguished career in medicine, specializing in rheumatology and family health. With extensive experience in clinical practice, he serves as a rheumatologist at the Hospital das ClĆ­nicas in Recife and at ClĆ­nica Reumatocare, where he provides expert care for patients with autoimmune and musculoskeletal diseases. His commitment to medical education is evident through his role as a professor at Faculdade Tiradentes in JaboatĆ£o dos Guararapes, where he mentors future healthcare professionals. Additionally, Dr. Pereira contributes to scientific research in health sciences and emerging medical technologies, further enhancing his impact on the field. His dual expertise in clinical practice and academia allows him to bridge the gap between research and patient care, ensuring innovative and evidence-based treatment approaches. Through his dedication to medicine, education, and research, Dr. Pereira continues to make significant contributions to rheumatology and overall healthcare advancements.

Research Interest

Dr. JosĆ© Kennedy Amaral Pereira’s research interests focus on rheumatology, autoimmune diseases, and innovative treatment approaches in musculoskeletal disorders. His work explores the pathophysiology, diagnosis, and management of conditions such as rheumatoid arthritis, lupus, and spondyloarthritis, aiming to enhance patient outcomes through evidence-based therapies. Additionally, he is deeply engaged in clinical research on biologic and targeted synthetic disease-modifying antirheumatic drugs (DMARDs), assessing their efficacy and safety in long-term disease control. Dr. Pereira also investigates the role of lifestyle interventions, including diet and exercise, in managing chronic inflammatory conditions. His research extends to family health and primary care, emphasizing the integration of rheumatology into general medical practice. By contributing to medical literature and participating in academic collaborations, he strives to advance knowledge in his field and improve healthcare strategies for patients with rheumatic diseases. His dedication to research underscores his commitment to innovation and excellence in medicine.

Award and Honor

Dr. JosƩ Kennedy Amaral Pereira has received numerous awards and honors in recognition of his outstanding contributions to rheumatology and medical research. His dedication to advancing the understanding and treatment of autoimmune and musculoskeletal diseases has earned him prestigious accolades from national and international medical organizations. He has been honored with excellence in research awards for his pioneering work on disease-modifying therapies in rheumatic conditions. Additionally, his contributions to medical education and clinical practice have been recognized through distinguished teaching awards and honorary fellowships from esteemed medical institutions. Dr. Pereira has also received grants and scholarships to support his groundbreaking studies in rheumatology, further solidifying his impact in the field. His active participation in medical conferences as a keynote speaker and his leadership roles in professional societies have garnered widespread recognition. These honors reflect his commitment to innovation, education, and improving patient care in rheumatology.

Research Skill

Dr. JosƩ Kennedy Amaral Pereira possesses a diverse and advanced set of research skills that have significantly contributed to the field of rheumatology and autoimmune diseases. His expertise includes clinical trial design, data analysis, and biostatistics, enabling him to conduct rigorous investigations into novel treatment approaches. He is proficient in molecular and immunological techniques, which have allowed him to explore the pathophysiology of rheumatic diseases at a cellular and genetic level. Additionally, his skills in systematic reviews and meta-analyses have provided valuable insights into evidence-based medicine. Dr. Pereira is also well-versed in epidemiological studies, utilizing large-scale patient data to identify disease patterns and treatment outcomes. His ability to integrate translational research with clinical applications has advanced therapeutic strategies for autoimmune disorders. Furthermore, his strong scientific writing and grant-writing abilities have facilitated successful research funding and high-impact publications, reinforcing his leadership in medical research.

Conclusion

JosƩ Kennedy Amaral Pereira is a strong candidate for the Best Scholar Award, given his high-impact publications, editorial roles, and contributions to rheumatology research. However, further international collaborations, research diversification, and leadership in academia would further solidify his position as a top contender.

Publications Top Noted

  • Chikungunya Fever and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
    Authors: JosĆ© Kennedy Amaral, Robert Taylor Schoen, Michael E. Weinblatt, Estelita Lima CĆ¢ndido
    Year: 2025
    Citation: Tropical Medicine and Infectious Disease, DOI: 10.3390/tropicalmed10020054

  • Bone erosions and joint damage caused by chikungunya virus: a systematic review
    Authors: JosƩ Kennedy Amaral, Peter Charles Taylor, Robert Taylor Schoen
    Year: 2024
    Citation: Revista da Sociedade Brasileira de Medicina Tropical, DOI: 10.1590/0037-8682-0433-2023

  • Chikungunya Arthritis Treatment with Methotrexate and Dexamethasone: A Randomized, Double-blind, Placebo-controlled Trial
    Authors: JosƩ Kennedy Amaral, Gabriela Lucena, Robert Taylor Schoen
    Year: 2024
    Citation: Current Rheumatology Reviews, DOI: 10.2174/0115733971278715231208114037

  • Quality of Life and Disability in Chikungunya Arthritis
    Authors: JosĆ© Kennedy Amaral, Peter C. Taylor, Michael E. Weinblatt, ƍcaro Bandeira, Robert T. Schoen
    Year: 2024
    Citation: Current Rheumatology Reviews, DOI: 10.2174/1573397119666230726113647

  • Extra-articular Manifestations of Chikungunya
    Authors: Jobson Lopes de Oliveira, Igor Albuquerque Nogueira, J. Kennedy Amaral, Luciana Ribeiro Campos, Mariana MacĆŖdo MilitĆ£o MendonƧa, MarĆ­lia de Brito Ricarte, Luciano Pamplona de GĆ³es Cavalcanti, Robert T. Schoen
    Year: 2023
    Citation: Revista da Sociedade Brasileira de Medicina Tropical, DOI: 10.1590/0037-8682-0341-2023

  • Pathogenesis of chronic chikungunya arthritis: Resemblances and links with rheumatoid arthritis
    Authors: J. Kennedy Amaral, Clifton O. Bingham III, Peter C. Taylor, Luis M. VilĆ”, Michael E. Weinblatt, Robert T. Schoen
    Year: 2023
    Citation: Travel Medicine and Infectious Disease, DOI: 10.1016/j.tmaid.2022.102534

 

 

 

Mallar Bhattacharya | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Mallar Bhattacharya | Medicine and Dentistry | Best Researcher Award

Associate Professor at UCSF, United States

Dr. Mallar Bhattacharya is an Associate Professor in Residence at the University of California, San Francisco (UCSF) in the Department of Medicine, Division of Pulmonary and Critical Care Medicine. With an extensive academic background, he earned his A.B. in Biology and Psychology from Harvard University, an M.Sc. in Neuroscience from Oxford University, and an M.D. from Harvard Medical School. His research focuses on lung fibrosis, acute lung injury, monocyte-derived macrophages, and cellular mechanisms in pulmonary diseases. Dr. Bhattacharya has received numerous honors, including the Will Rogers Institute Fellowship and recognition from the UCSF Bakar Aging Research Institute. He has served in leadership roles within the American Thoracic Society and as a reviewer for high-impact journals such as Nature, Cell, and Immunity. Actively engaged in both clinical practice and medical education, he mentors trainees and contributes to advancing critical care and pulmonary medicine through his research and teaching efforts.

Professional ProfileĀ 

Education

Dr. Mallar Bhattacharya has an extensive and prestigious academic background, reflecting his dedication to medical research and education. He earned his A.B. in Biology and Psychology from Harvard University, where he developed a strong foundation in the life sciences. He then pursued an M.Sc. in Neuroscience at Oxford University, gaining expertise in neurological and cellular mechanisms. Continuing his medical education, he obtained his M.D. from Harvard Medical School, one of the world’s leading institutions for medical training and research. His advanced studies equipped him with a deep understanding of pulmonary and critical care medicine, leading him to specialize in lung fibrosis, acute lung injury, and monocyte-derived macrophages. His academic journey has been marked by interdisciplinary learning, blending neuroscience, psychology, and medicine to advance pulmonary research. His education has provided the foundation for his contributions to medical science, clinical practice, and mentoring the next generation of researchers and physicians.

Professional Experience

Dr. Mallar Bhattacharya has built a distinguished career in pulmonary and critical care medicine, with a focus on research, clinical practice, and education. He serves as an Associate Professor at the University of California, San Francisco (UCSF), where he conducts groundbreaking research on lung fibrosis, acute lung injury, and monocyte-derived macrophages. As a practicing physician, he provides expert care to patients suffering from complex respiratory conditions, integrating the latest scientific advancements into clinical treatment. His leadership extends to mentoring medical students, residents, and fellows, shaping the next generation of researchers and clinicians. Dr. Bhattacharyaā€™s work has been widely recognized through numerous grants and publications, contributing significantly to the understanding of pulmonary diseases. His commitment to academic medicine ensures that his research translates into meaningful medical advancements, improving patient outcomes and advancing the field of respiratory medicine. Through his work at UCSF, he continues to drive innovation in pulmonary research and treatment.

Research Interest

Dr. Mallar Bhattacharya’s research focuses on understanding the mechanisms underlying lung fibrosis, acute lung injury, and the role of immune cells in pulmonary diseases. His work explores how monocyte-derived macrophages contribute to lung inflammation and fibrosis, aiming to uncover novel therapeutic targets for conditions such as idiopathic pulmonary fibrosis (IPF) and acute respiratory distress syndrome (ARDS). By integrating molecular biology, immunology, and advanced imaging techniques, Dr. Bhattacharya investigates the cellular interactions that drive chronic lung disease progression. His research also delves into the signaling pathways that regulate immune responses in the lungs, with the goal of identifying strategies to modulate these pathways for improved treatment outcomes. Through his studies, he aims to bridge the gap between basic science and clinical application, ultimately translating laboratory discoveries into effective therapies. His contributions significantly enhance the understanding of pulmonary disease mechanisms and hold promise for developing targeted interventions in respiratory medicine

Award and Honor

Dr. Mallar Bhattacharya has been recognized with several prestigious awards and honors throughout his academic and professional career. During his undergraduate studies at Harvard College, he was consistently on the Dean’s List from 1994 to 1998 and was awarded the John Harvard Scholarship in 1995, 1997, and 1998 for his outstanding academic performance. In 1997, he was inducted into the Phi Beta Kappa Society, reflecting his exceptional scholarly achievements. He also received the New York State Robert C. Byrd Honors Scholarship during his time at Harvard. In 2000, Dr. Bhattacharya was honored with both the Pasteur Summer Research Fellowship for Medical Students and the American Neurological Association Summer Fellowship, supporting his early research endeavors. Later, in 2008-2009, he was awarded the Will Rogers Institute Fellowship, recognizing his contributions to pulmonary research. These accolades underscore Dr. Bhattacharya’s commitment to excellence in research and education.

Research Skill

Dr. Mallar Bhattacharya possesses a diverse set of research skills, particularly in the fields of pulmonary medicine, immunology, and fibrosis. His expertise includes advanced molecular and cellular biology techniques, allowing him to investigate complex disease mechanisms at a fundamental level. He is proficient in in vivo and in vitro models of lung disease, which he utilizes to explore the pathophysiology of pulmonary fibrosis and related conditions. Additionally, Dr. Bhattacharya has extensive experience in bioinformatics and data analysis, enabling him to interpret large datasets for translational research. His skill set also includes microscopy, flow cytometry, and genetic manipulation techniques, which he applies to study immune cell interactions in disease progression. Furthermore, his ability to integrate experimental findings with clinical insights enhances the impact of his research. Dr. Bhattacharya’s multidisciplinary approach and technical expertise contribute significantly to advancing scientific knowledge in lung disease and immune regulation.

Conclusion

Dr. Mallar Bhattacharya is a highly suitable candidate for the Best Researcher Award, given his cutting-edge research in pulmonary medicine, leadership in academia, and strong international reputation. His work on lung fibrosis and cellular immunity has significant translational potential. While additional landmark publications and broader leadership in global research initiatives would enhance his profile, his current contributions make him an outstanding contender for this award.

Publications Top Noted

  • Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage
    Authors: D Aran, AP Looney, L Liu, E Wu, V Fong, A Hsu, S Chak, RP Naikawadi, …
    Year: 2019
    Citations: 3461

  • Case 81: Antiphospholipid antibody syndrome with adrenal hemorrhage and Budd-Chiari syndrome
    Authors: M Bhattacharya, BM Yeh, A Qayyum, FV Coakley
    Year: 2005
    Citations: 310

  • Negative-pressure pulmonary edema
    Authors: M Bhattacharya, RH Kallet, LB Ware, MA Matthay
    Year: 2016
    Citations: 212

  • Impact of FDG PET on defining the extent of disease and on the treatment of patients with recurrent or metastatic breast cancer
    Authors: WB Eubank, D Mankoff, M Bhattacharya, J Gralow, H Linden, G Ellis, …
    Year: 2004
    Citations: 172

  • Absence of integrin Ī±vĪ²3 enhances vascular leak in mice by inhibiting endothelial cortical actin formation
    Authors: G Su, A Atakilit, JT Li, N Wu, M Bhattacharya, J Zhu, JE Shieh, E Li, …
    Year: 2012
    Citations: 100

  • Molecular programs of fibrotic change in aging human lung
    Authors: S Lee, MN Islam, K Boostanpour, D Aran, G Jin, S Christenson, …
    Year: 2021
    Citations: 61

  • Immunology of human fibrosis
    Authors: M Bhattacharya, P Ramachandran
    Year: 2023
    Citations: 56

  • Globular domains 4/5 of the laminin Ī±3 chain mediate deposition of precursor laminin 5
    Authors: RO Sigle, SG Gil, M Bhattacharya, MC Ryan, TM Yang, TA Brown, …
    Year: 2004
    Citations: 56

  • Invariant natural killer T cells coordinate removal of senescent cells
    Authors: S Arora, PJ Thompson, Y Wang, A Bhattacharyya, H Apostolopoulou, …
    Year: 2021
    Citations: 50

  • Counter regulation of spic by NF-ĪŗB and STAT signaling controls inflammation and iron metabolism in macrophages
    Authors: Z Alam, S Devalaraja, M Li, TKJ To, IW Folkert, E Mitchell-Velasquez, …
    Year: 2020
    Citations: 46

  • Effective treatment of mouse sepsis with an inhibitory antibody targeting integrin Ī±vĪ²5
    Authors: G Su, A Atakilit, JT Li, N Wu, J Luong, R Chen, M Bhattacharya, …
    Year: 2013
    Citations: 37

David Kopsky | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Mr. David Kopsky | Medicine and Dentistry | Best Researcher Award

Anesthesiology at Amsterdam medical center, Netherlands

Dr. David J. Kopsky, MD, is a distinguished medical doctor and researcher specializing in neuropathic pain management. As the founder of the Institute for Neuropathic Pain in the Netherlands, he has dedicated his career to pioneering innovative pain treatments, particularly in topical analgesics. With extensive experience in clinical operations, he has led groundbreaking research on phenytoin cream and other topical formulations for chronic pain relief. Dr. Kopsky has contributed significantly to the field through numerous high-impact publications in renowned medical journals. His leadership extends to co-founding the Pain Medical Center and chairing various scientific and medical foundations. His work integrates conventional and complementary medicine, reflecting his expertise in acupuncture, hypnotherapy, and rehabilitation. As an active member of multiple professional societies, he continues to shape the future of pain management through clinical trials, patient-centered research, and interdisciplinary collaboration. His contributions make him a strong candidate for the Best Researcher Award.

Professional ProfileĀ 

Education

Dr. David J. Kopsky pursued his medical education at a prestigious institution, earning his Doctor of Medicine (MD) degree with a strong focus on neurology and pain management. His academic journey emphasized both conventional and complementary medicine, equipping him with a multidisciplinary approach to treating neuropathic pain. Furthering his expertise, he specialized in acupuncture, hypnotherapy, and rehabilitation techniques, integrating these fields into his medical practice. Dr. Kopskyā€™s commitment to advancing pain management led him to engage in extensive clinical research, where he explored innovative treatments such as topical analgesics. His educational background, enriched by continuous professional development and scientific inquiry, has positioned him as a leading expert in his field. Through his academic and clinical training, he has cultivated a unique approach that bridges traditional and alternative medicine, reinforcing his reputation as a pioneer in neuropathic pain research and treatment.

Professional Experience

Dr. David J. Kopsky has an extensive professional background in neurology and pain management, with a focus on innovative treatments for neuropathic pain. As the founder and medical director of the Institute for Neuropathic Pain, he has dedicated his career to developing and applying novel therapeutic approaches, particularly in the use of topical analgesics. His expertise extends to acupuncture, hypnotherapy, and rehabilitation, which he integrates into patient care to provide holistic treatment solutions. Dr. Kopsky has been actively involved in clinical research, contributing to numerous scientific publications that explore new pain management strategies. His work has led to significant advancements in non-invasive pain relief techniques, making him a respected authority in his field. In addition to his clinical practice, he collaborates with international researchers and medical institutions, furthering the development of effective and accessible pain management therapies for patients worldwide.

Research Interest

Dr. David J. Kopsky’s research interests focus on developing innovative treatments for neuropathic pain, with a particular emphasis on topical analgesics and non-invasive therapeutic approaches. He explores the effectiveness of novel drug combinations, including phenytoin-based topical formulations, to provide targeted pain relief with minimal systemic side effects. His work integrates traditional and modern techniques, incorporating acupuncture, hypnotherapy, and rehabilitation methods to enhance patient outcomes. Dr. Kopsky is also deeply interested in understanding the mechanisms of chronic pain and optimizing individualized treatment plans through precision medicine. His research extends to rare and treatment-resistant neuropathic conditions, aiming to offer new hope for patients with limited options. Through collaborations with international researchers and healthcare institutions, he continues to advance the field of pain management, striving to improve the quality of life for individuals suffering from chronic and debilitating pain disorders.

Award and Honor

Dr. David J. Kopsky has made significant contributions to neuropathic pain management, particularly through his work with topical phenytoin formulations. He is a co-holder of two patents: one for the use of topical phenytoin in treating peripheral neuropathic pain and another for a topical pharmaceutical composition containing phenytoin combined with a co-analgesic for chronic pain treatment. Additionally, Dr. Kopsky has received licensing fees from Xeolas Pharmaceuticals for his innovations. While specific awards and honors are not detailed in the available information, his patented work and industry recognition underscore his impactful contributions to pain management research.

Research Skill

Dr. David J. Kopsky possesses extensive research skills in the field of neuropathic pain management, particularly in the development and clinical application of topical analgesics. His expertise lies in pharmacological innovation, evidenced by his pioneering work with topical phenytoin formulations for treating peripheral neuropathic pain. He has a strong background in clinical research, conducting trials to assess the efficacy and safety of novel pain treatments. His skills in experimental design, data analysis, and scientific writing have contributed to several peer-reviewed publications. Dr. Kopsky is also proficient in interdisciplinary collaboration, working alongside pharmaceutical companies and medical researchers to translate laboratory findings into practical therapeutic solutions. His ability to identify gaps in existing pain management strategies and develop targeted pharmaceutical interventions showcases his problem-solving and critical thinking skills. His research is driven by a commitment to improving patient outcomes, making his contributions valuable in both academic and clinical settings.

Conclusion

Dr. David J. Kopsky is a highly qualified candidate for the Best Researcher Award, with significant contributions to neuropathic pain management, clinical research, and translational medicine. His leadership in pain research and strong publication record make him a strong contender. However, finalizing his PhD and increasing high-impact publications could further enhance his candidacy. If the award criteria prioritize clinical innovation and translational impact, he would be an excellent choice.

Publications Top Noted

  • Enriched enrollment randomized double-blind placebo-controlled cross-over trial with phenytoin cream in painful chronic idiopathic axonal polyneuropathy (EPHENE): a study protocol

    • Authors: D.J. Kopsky, R.P.A. van Eijk, J.K. Warendorf, N.C. Notermans, A.F.J.E. Vrancken
    • Year: 2022
    • Citations: 2

  • Pulsed Radiofrequency Increases Nestin and Matrix Metalloproteinase-2 Expression in Porcine Lumbar Dorsal Root Ganglion

    • Authors: M. Arons, M. Pilmane, A.K. Bhaskar, V.I. Romanenko, O.J.J.M. Rohof
    • Year: 2022
    • Citations: 1

  • Study Design Characteristics and Endpoints for Enriched Enrollment Randomized Withdrawal Trials for Chronic Pain Patients: A Systematic Review

    • Authors: D.J. Kopsky, K.M. Szadek, P.R. Schober, A.F.J.E. Vrancken, M.A. Steegers
    • Year: 2022
    • Citations: 4

  • No Detectable Phenytoin Plasma Levels After Topical Phenytoin Cream Application in Chronic Pain: Inferences for Mechanisms of Action

    • Authors: D.J. Kopsky, J.M. Keppel Hesselink, A.L. Russell, A.F.J.E. Vrancken
    • Year: 2022
    • Citations: 3